The U.S. healthcare system wastes between $760 billion and $1.6 trillion every year. That range comes from a landmark 2019 JAMA study and updated 2025 expenditure data from CMS. If you work in insurance or risk management, that number should stop you cold. It is larger than the GDP of most countries. It represents roughly 25-30% of total national health expenditure. And the researchers who quantified it also confirmed something important: proven interventions could save $191 billion to $282 billion annually.
This is not a projection based on theoretical models. It is a documented opportunity sitting inside the claims data of every self-insured health plan in America.
Where the Waste Lives
JAMA identified six categories of waste: billing errors and fraud, administrative complexity, unnecessary services, pricing failures, failure of care coordination, and other inefficiencies including underuse of preventive care. Each category is quantifiable. Each has known interventions. None of them require inventing technology or waiting for policy reform.
Consider the pricing problem alone. An echocardiogram can cost $350 at one facility and $2,700 at another in the same market, with no corresponding difference in quality. The Purchaser Business Group on Health (PBGH) found that commercial negotiated rates for identical procedures vary by more than 100% between regional markets. The primary driver of excess U.S. spending is higher prices, not greater usage. Americans use many healthcare services at lower rates than peers in other developed nations but pay far more for the same services.
On the pharmacy side, brand-name drugs are routinely dispensed when therapeutically equivalent generics exist at a fraction of the cost. PBM spread pricing, where the pharmacy benefit manager charges the plan one price and pays the pharmacy a lower price, persists because most employers never examine their claims data and their vendor contracts at the line-item level. Organizations that shift to transparent, pass-through pharmacy pricing models are documenting savings of 15-30% on pharmacy spend.
These are not outlier cases. They are structural patterns that repeat across virtually every health plan I have analyzed over the past decade. These analyses and corroborating studies consistently indicate that about half of all employer-sponsored health plan spending is inefficient or wasteful.
Why the Problem Persists
The most dangerous aspect of healthcare waste is that it hides in plain sight. It does not appear as a line item labeled "unnecessary" or "inefficient." It is buried in inflated claims, redundant procedures, opaque vendor clauses, and recurring overpayments to providers.
Many employers rely on their chosen third-party administrators, insurance brokers, or pharmacy benefit managers to manage most aspects of their plans. In a system riddled with misaligned incentives, that trust is often misplaced. When PBMs, for example, profit from higher usage of certain high-cost drugs or maintain deliberately opaque rebate arrangements, waste is not just tolerated. It is the business model!
The traditional cost-control approach is entirely reactive. An employer negotiates rates during contracting season, processes claims throughout the year, and then hires an auditor to review a random sample once or twice annually. By the time anyone identifies an overpayment or a suspicious billing pattern, the money is long gone. Recovering it requires time, administrative effort, and often a fight with the provider or vendor. Most employers never recoup the full amount, if they recoup anything.
The Intervention Point Has Shifted
AI and advanced analytics have moved the intervention point forward. Instead of reviewing claims after they have been paid, AI-powered platforms can analyze claims before payment is released. Every claim is fed through thousands of logic checks based on CMS guidelines, billing codes, plan-specific terms, and more. When a claim triggers a flag for a duplicate charge, an upcoded procedure, unbundling, or a charge exceeding contracted rates, the system can pause or deny payment until the issue is reviewed by a human. That is a fundamental shift from recovering waste after the fact to preventing it from occurring in the first place.
Predictive modeling takes this further upstream. Predictive engines analyze historical claims data, clinical indicators, pharmacy usage, and demographic profiles to identify plan members likely to become high-cost members in the coming months. When the model flags a member as high-risk for a cardiovascular event or a deteriorating chronic condition, care managers can intervene proactively. They can coordinate outreach, adjust treatment plans, and connect the member with resources before a $200,000 hospitalization shows up in the claims data. Prevention at that scale was never achievable through manual review.
Price transparency data, now available through federally mandated machine-readable payer files, gives employers another tool to act earlier. AI transforms that raw pricing data into market-by-market comparisons. Employers can identify where a plan is overpaying for specific medical services and direct members toward higher-value providers before care occurs, rather than negotiating discounts after the bill arrives.
The Fiduciary Dimension
Self-insured employers now provide health coverage for more than 160 million Americans. Approximately 67% of insured U.S. workers are covered by self-funded arrangements, and among large employers with 5,000 or more employees, adoption rates reach 95%. These organizations collectively spend hundreds of billions of dollars annually on health plan costs.
Under ERISA and the Consolidated Appropriations Act (CAA), these employers have explicit fiduciary obligations. They must ensure health plan dollars are spent prudently, demand transparency from TPAs, PBMs, and other vendors, and act in the best interest of plan participants. The CAA reinforces this by mandating that TPAs and PBMs disclose detailed claims and pricing information. Elizabeth Mitchell, president and CEO of PBGH, has stated clearly that self-insured employers need to take on a significantly larger role in selecting and managing their health care vendors and partners.
This is a critical point for insurance professionals. Stop-loss carriers, group health underwriters, brokers, and consultants all operate within an ecosystem shaped by employer health plan performance. When waste drives up claims, it drives up stop-loss premiums, reduces margins, and creates volatility that makes risk harder to price. Conversely, employers who actively identify and eliminate waste produce a cleaner, more predictable claims experience. That benefits everyone in their value chain.
What the Numbers Look Like in Practice
When an employer deploys AI-powered claims auditing on a $50 million health plan and identifies a 14% payment inaccuracy rate, typical for most small to mid-size plans, it recovers more than $7 million annually. That money would otherwise flow to vendor margins rather than employee benefits. Organizations using this approach routinely achieve 20% to 30% cost reductions in the first year.
The waste is not distributed randomly. It accumulates in specific, repeating patterns: duplicate charges, inflated facility fees, upcoded procedures, PBM spread pricing, and avoidable usage. These patterns are identifiable, measurable, and correctable with the tools available today.
The Only Remaining Question
The convergence of regulatory requirements, data transparency mandates, and AI-powered analytics gives self-insured employers unprecedented ability to identify and eliminate waste. The tools exist. The fiduciary mandate is clear. Healthcare costs have exceeded 5% in annual increases for three consecutive years, with 2025 projections at 5.8% and 2026 at 6.5%.
Every dollar recovered from waste is a dollar that can fund better benefits, lower premiums, or reinvestment in the workforce. The employers who act on this with data, transparency, accountability, and the right technology will control their costs effectively. They will set the standard for how healthcare should be managed in this country. The rest will keep paying for waste they could have prevented and harboring risk they could have eliminated.
